v3.25.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (2,258,898) $ (988,320)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 83,199 272,615
Common stock and stock option based compensation for employees and board of directors 573,775 407,231
Net gain on divestiture of subsidiaries (1,397,066)
Reserve on note received in connection with divestiture of subsidiaries 1,500,000
Gain on office lease termination (34,660)
Acquisition contingent consideration fair value adjustment 16,417 61,480
Adjustment to operating lease right-of-use assets and liabilities (5,597) (41,787)
Changes in operating assets and liabilities:    
Accounts receivable 278,663 (668,847)
Deferred costs (512,592) (52,003)
Loans receivable (40,900)
Prepaid expenses and other current assets (44,682) 99,757
Other assets 5,349
Accounts payable (141,796) 114,108
Accrued liabilities (208,313) 295,521
Deferred revenue 190,401 214,369
Net cash used in operating activities (2,029,423) (253,153)
Cash flow from investing activities:    
Purchase of leasehold improvements and equipment (16,189) (26,406)
Payment of contingent consideration for acquisition (1,500,000)
Cash used in investing activities (1,516,189) (26,406)
Cash flows provided by financing activities:    
Notes receivable repayments (issuance) 55,600 (84,000)
Proceeds from securities purchase agreement, net 6,785,552
Proceeds from exercise of warrants 175,000
Net cash provided by financing activities 55,600 6,876,552
Net change in cash and cash equivalents (3,490,012) 6,596,993
Cash and cash equivalents, beginning of period 6,832,725 1,848,295
Cash and cash equivalents, end of period $ 3,342,713 $ 8,445,288